Original Article
Copyright copy;2010 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2010; 16(33): 4145-4151
Published online Sep 7, 2010. doi: 10.3748/wjg.v16.i33.4145
Figure 4
Figure 4 Expression of tumor necrosis factor-α mRNA. Lane 1: Control group; Lane 2: Probiotic group; Lane 3: Sulfasalazine group; Lane 4: Ulcerative colitis patients before treatment. TNF-α: Tumor necrosis factor-α.